Generation of an induced pluripotent stem cell line (IPCASi001-A) from an autism spectrum disorder individual without intellectual disability.

Scientists created special stem cells from a person with autism who has normal intelligence. These cells can be grown in the lab and turned into different types of brain cells. This will help researchers study what causes autism in people who don't have intellectual disabilities, which could lead to better understanding of how autism affects the brain.

Researchers successfully created an induced pluripotent stem cell (iPSC) line from a person with autism spectrum disorder who has normal intellectual abilities (IQ > 70). The individual demonstrates impaired social function and restricted repetitive behaviors characteristic of ASD. The cell line was validated through morphological assessment, gene expression analysis, and confirmation of its ability to differentiate into all three germ layers. This cellular model provides a research tool to investigate the underlying pathophysiological and molecular mechanisms specific to ASD patients without intellectual disability, potentially revealing insights into autism that are independent of cognitive impairment.

While not directly therapeutic, this research tool may advance understanding of autism pathophysiology in individuals without intellectual disability, potentially informing future targeted interventions and personalized treatment approaches.

This is a single case study establishing a cell line rather than investigating therapeutic outcomes. No functional studies or mechanistic insights are reported in this work, limiting immediate clinical applications.

Autism spectrum disorder (ASD) is a highly inheritable neurodevelopmental disorder that causes diverse deficits in social communication and restricted repetitive sensorimotor behaviors. Here, we studied a human-induced pluripotent cell line from an autistic patient with impaired social function and a normal intelligence quotient (IQ > 70). The cell line was validated by its morphology, gene expression, and potential to differentiate into three germ layers. This model can be used to explore the pathophysiological and molecular mechanisms in patients with ASD, compared those of with patients with normal cognitive abilities.